.

CanSino's COVID-19 vaccine candidate approved for military use in China

Reuters•June 29, 2020


"BEIJING (Reuters) - China's military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics <6185.HK> after clinical trials proved it was safe and somewhat efficient, the company said on Monday.

The Ad5-nCoV is one of the eight vaccine candidates being developed by Chinese companies and researchers approved to be moved into human trials for the respiratory disease caused by the new coronavirus.

The shot also won approval for human testing in Canada."

https://news.yahoo.com/cansinos-covid-19...20157.html

============================================


"The company has a portfolio of vaccines under research including Ad5-nCoV for COVID-19, developed jointly with the Institute of Biotechnology of the Academy of Military Medical Sciences of the People's Liberation Army.

The company has collaborated with the National Research Council of Canada (NRC) on vaccine development.

In March 2020, CanSino made a deal to collaborate with the NRC on development of the COVID-19 vaccine candidate Ad5-nCoV, to help end the COVID-19 pandemic, with plans to conduct a clinical trial in Canada. Ad5-nCoV was the first COVID-19 vaccine candidate in the world to begin Phase II human trials."

https://en.wikipedia.org/wiki/CanSino_Biologics